25
Clinical Manifests
100+
Safety Triggers
18
Anatomical Points
14
Drug Interactions

The Operating System
for Peptide Research

Built on 25 Clinical Manifests, 100+ Safety Triggers, and 18-Point Anatomical Precision.

THE BRAIN

Clinical Logic
Under the Hood

Every recommendation passes through our Safety Engine - a rule-based system built on peer-reviewed research and clinical protocols.

Fatal
Warning
Caution
safety-engine.ts
// if (GHS + History of Cancer) {
return { BLOCK }
}

Growth hormone secretagogues can accelerate malignant cell proliferation

// if (Route === "IV" && Peptide === "Ipamorelin") {
return { FATAL RISK }
}

IV administration causes rapid cardiovascular collapse

// if (Metformin + MOTS-c) {
return { AMPK OVERLAP WARNING }
}

Both compounds activate AMPK pathway - monitor for hypoglycemia

// if (ContinuousUse > 84 days) {
return { ENFORCE WASHOUT }
}

Pituitary desensitization requires 4-6 week recovery period

BIMODAL PRECISION

One Dose.
Every Hardware.

Whether you use a 0.3mL insulin syringe or a 1.0mL standard syringe, we calculate the exact draw volume to the hundredth of a unit.

0.3mL
Insulin Syringe
051015202530
0 units
= 300mcg dose
1.0mL
Standard Syringe
0102030405060708090100
0 units
= 300mcg dose
Pen Device
Click-Dial Dosing
0clicks
0mcg
@ 50mcg per click

Same reconstitution (5mg in 2mL BAC water) = Same dose (300mcg) = Different draw volumes.
The math is done for you.

GLOBAL SAFETY GUARD

100+ Triggers.
Zero Blind Spots.

Every flag below is actively monitored. Drug interactions, contraindications, scheduling conflicts - we've closed the 2% gap that other apps ignore.

Fatal/Cancer
Warning
Drug Interaction
Scheduling
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
IV Ipamorelin
→ Cardiovascular Collapse
Critical Illness + GHRP-2
→ Multi-Organ Failure
Active Malignancy + IGF-1 Peptides
→ Tumor Progression
Melanocytic Lesions + Melanotan
→ Melanoma Acceleration
Lynch Syndrome + CJC-1295
→ Colorectal Cancer Risk
High Immunogenicity + Repeated Use
→ Antibody Formation
SSRIs + Semax
→ Serotonin Syndrome Risk
Insulin + GLP-1 Agonists
→ Severe Hypoglycemia
Beta Blockers + Ipamorelin
→ Bradycardia Risk
NSAIDs + TB-500
→ Reduced Efficacy
ACE Inhibitors + AOD-9604
→ Hypotension Risk
Anticoagulants + Epithalon
→ Bleeding Risk
GH Secretagogue < 2hr Post-Meal
→ Blunted Release
DSIP + Daytime Administration
→ Drowsiness Risk
Pulsing Protocol Violation
→ Pituitary Fatigue
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
Sauna + Alcohol + GH Secretagogues
→ Hypotensive Crisis
Tesamorelin + Acute Infection
→ Septic Shock Risk
MEN 2 Syndrome + GLP-1 Agonists
→ Medullary Thyroid Cancer
History of Cancer + Growth Hormone
→ Recurrence Risk
Bovine Sensitivity + TB-500
→ Allergic Reaction
Metformin + MOTS-c
→ AMPK Pathway Overlap
SNRIs + Selank
→ Serotonergic Interaction
Warfarin + Semaglutide
→ Altered Gastric Emptying
Corticosteroids + BPC-157
→ Healing Interference
Thyroid Meds + Tesamorelin
→ TSH Suppression
Statins + MOTS-c
→ Myopathy Risk
Immunosuppressants + Thymalin
→ Immune Dysregulation
CJC-1295 + Morning Cortisol
→ Suboptimal Timing
BPC-157 > 12 Weeks Continuous
→ Receptor Downregulation
Metabolic Class Switch < 90 Days
→ Washout Violation
30
Active Safety Monitors
ANATOMICAL PRECISION

18-Point Rotation Grid

User sovereignty means you control which sites are active. Exclude injured areas, set preferences, and let the rotation engine do the rest.

Anatomical injection site mapping
18 Injection Sites
Intelligent Rotation

6 Anatomical Zones

Deltoids
SubQ / IM compatible
2
sites
Abdomen
SubQ compatible
4
sites
Thighs
SubQ / IM compatible
4
sites
Glutes
IM compatible
4
sites
Triceps
SubQ compatible
2
sites
Love Handles
SubQ compatible
2
sites
Total Sites18
Symmetrical Pair Logic
Tap one side, both activate. Long-press to disable individual sites for injuries.
OPEN SOURCE LOGIC

Logic Explorer

Built with Transparency. No Black-Box Logic.
Only Research-Backed Precision.

Drug-Peptide Interaction Check

safety-guard.ts + drug-interactions.ts

// Drug-Peptide Interaction Check
checkDrugInteractions(profile: 400">UserProfile, peptideIds: 400">string[]): 400">DrugInteractionMatch[] {
  400">const matches: 400">DrugInteractionMatch[] = []
  400">for (400">const interaction 400">of DRUG_INTERACTIONS) {
    400">const userHasDrug = this.userHasMedication(profile, interaction.drugKey)
    400">if (!userHasDrug) continue
    400">for (400">const peptideId 400">of peptideIds) {
      400">if (interaction.conflictingPeptides.includes(peptideId)) {
        matches.push({
          interaction,
          userDrug: interaction.drugName,
          conflictingPeptide: peptideId,
          severity: interaction.severity,
        })
      }
    }
  }
  400">return matches
}
// Example Interaction Data
{
  drugName: 400">'Insulin',
  conflictingPeptides: [400">'semaglutide', 400">'tirzepatide'],
  mechanism: 400">'Increased risk 400">of severe hypoglycemia',
  severity: 400">'critical',
}

All logic is auditable. No hidden algorithms. No proprietary black boxes.